Literature DB >> 29868788

Mortality, length of stay and cost of hospitalization among patients with systemic sclerosis: results from the National Inpatient Sample.

Dilli Ram Poudel1, Michael George2, Rashmi Dhital1, Paras Karmacharya1,3, Nora Sandorfi2, Chris T Derk2.   

Abstract

Objectives: To evaluate the hospitalizations and define the factors associated with in-hospital mortality, longer length of stay (LOS) and higher hospital costs among SSc hospitalizations.
Methods: We used the National Inpatient Sample (2012-13) to identify adult hospitalizations with SSc, excluding patients with concomitant diagnosis of RA and systemic lupus. We calculated rates of hospitalization, in-hospital mortality, LOS and hospital costs. Factors associated with these outcomes were evaluated by univariate and backward stepwise multivariate logistic regression.
Results: There were 9731 hospitalizations in the sample representing an estimated 48 655 hospitalizations nationwide with SSc (0.09%), and the inpatient mortality rate was 5%. Patients were predominantly older (mean age 63.2 years), female (82.2%) and Caucasian (71.5%). Infections were the most common primary diagnoses among SSc hospitalizations (17.4%) and among those who died (32.7%). Acute renal failure [adjusted odds ratio (aOR) = 4.3, 95% CI: 3.3, 5.6] and aspiration (aOR= 3.5, 95% CI: 2.5, 4.9) were strongly associated with in-hospital mortality. The median (interquartile range) LOS was 4 days (-2, 7), and the median (interquartile range) cost was $8885 (-5169, 15921). While hospital from the West region, acute renal failure, acute bowel obstruction and aspiration (aOR > 2.0 with P < 0.0001 for all) seem to predict higher cost of hospitalization, pulmonary fibrosis, myositis and any type of infection in addition to the same factors, except the West region (aOR > 2.0 with P < 0.0001 for all), were associated with longer LOS.
Conclusion: Infections are currently the most common diagnoses among SSc hospitalizations and in-hospital deaths. This emphasizes the importance of being vigilant in prevention and early treatment of infections in SSc patients.

Entities:  

Mesh:

Year:  2018        PMID: 29868788     DOI: 10.1093/rheumatology/key150

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  9 in total

Review 1.  Real-world evidence in rheumatic diseases: relevance and lessons learnt.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2019-02-06       Impact factor: 2.631

2.  Systemic sclerosis is associated with knee arthroplasty outcomes: a National US study.

Authors:  Jasvinder A Singh; John D Cleveland
Journal:  Clin Rheumatol       Date:  2019-08-23       Impact factor: 2.980

3.  Reasons for hospitalization and in-hospital mortality in adults with systemic sclerosis: Analysis of the National Inpatient Sample.

Authors:  Joanna Potera; Augustine M Manadan
Journal:  J Scleroderma Relat Disord       Date:  2022-05-11

4.  Acute hospitalization in a cohort of patients with systemic sclerosis: a 10-year retrospective cohort study.

Authors:  Joana Caetano; Frederico Batista; Marta C Amaral; Susana Oliveira; José D Alves
Journal:  Rheumatol Int       Date:  2021-09-03       Impact factor: 3.580

5.  Hospitalisations related to systemic sclerosis and the impact of interstitial lung disease. Analysis of patients hospitalised at the University of Michigan, USA.

Authors:  Shobana Sankar; Mirette Habib; Sara Jaafar; Vivek Nagaraja; David Roofeh; Amber Young; Suiyuan Huang; Dinesh Khanna
Journal:  Clin Exp Rheumatol       Date:  2021-03-10       Impact factor: 4.862

6.  Serious infections in people with systemic sclerosis: a national US study.

Authors:  Jasvinder A Singh; John D Cleveland
Journal:  Arthritis Res Ther       Date:  2020-06-29       Impact factor: 5.156

7.  Association Between Uric Acid and Worsening Peripheral Microangiopathy in Systemic Sclerosis.

Authors:  Eleni Pagkopoulou; Stergios Soulaidopoulos; Eva Triantafyllidou; Afrodite Malliari; George D Kitas; Alexandros Garyfallos; Theodoros Dimitroulas
Journal:  Front Med (Lausanne)       Date:  2021-12-24

Review 8.  Current Take on Systemic Sclerosis Patients' Vaccination Recommendations.

Authors:  Giuseppe Murdaca; Giovanni Noberasco; Dario Olobardi; Claudio Lunardi; Matteo Maule; Lorenzo Delfino; Massimo Triggiani; Chiara Cardamone; Devis Benfaremo; Gianluca Moroncini; Angelo Vacca; Nicola Susca; Sebastiano Gangemi; Paola Quattrocchi; Laura Sticchi; Giancarlo Icardi; Andrea Orsi
Journal:  Vaccines (Basel)       Date:  2021-12-02

9.  Hospitalization Rates Are Highest in the First 5 Years of Systemic Sclerosis: Results From a Population-based Cohort (1980-2016).

Authors:  Caitrin M Coffey; Avneek S Sandhu; Cynthia S Crowson; Sara J Achenbach; Eric L Matteson; Thomas G Osborn; Kenneth J Warrington; Ashima Makol
Journal:  J Rheumatol       Date:  2020-11-15       Impact factor: 5.346

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.